Subramaniam Thirusivapragasam, Dearani Joseph A, Stulak John M, Lahr Brian, Lee Alex, Miller Jordan D
Departments of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, USA.
Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Mayo Clin Proc. 2025 Feb;100(2):220-234. doi: 10.1016/j.mayocp.2024.08.027. Epub 2025 Jan 4.
To study the effectiveness of virtual reality (VR) in reducing anxiety levels in patients undergoing first-time sternotomy for cardiac surgery.
A total of 100 adult patients scheduled for cardiac surgery at Mayo Clinic in Rochester, Minnesota, USA, was recruited from April 19, 2022, to October 12, 2022. Before surgery, patients wore a physiological monitor to record vital signs. On the day of surgery, patients completed the State-Trait Anxiety Inventory (STAI) and were randomized into two groups: one receiving a tablet-based intervention (control) and the other an immersive VR experience in the preoperative holding area. After the interventions, patients repeated the state anxiety component of the STAI.
The results showed that overall state anxiety scores decreased an average of 2.0 points with tablet treatment, but this change failed to reach statistical significance. However, 6 of 20 specific state anxiety features significantly improved with tablet treatment whereas 1 feature significantly worsened. With the VR experience, overall state anxiety scores were significantly reduced by an average of 2.9 points, with improvement in seven state anxiety features (three of which did not overlap with the tablet intervention). Despite a greater reduction in the STAI score with the VR experience, there were no significant differences in the anxiolytic responses between groups. Physiologically, both tablet and VR treatments slightly but significantly reduced pulse rate, with no difference between the groups.
Overall, the findings suggest that treatment of older adults with an immersive VR experience before cardiac surgery can significantly reduce overall anxiety. Further investigation determining how such interventions can be optimally implemented in surgical practices and whether such interventions reduce the need for anxiolytic medications and improve the overall patient experience is needed.
研究虚拟现实(VR)对首次接受心脏手术胸骨切开术患者焦虑水平的降低效果。
2022年4月19日至2022年10月12日,从美国明尼苏达州罗切斯特市梅奥诊所招募了100名计划进行心脏手术的成年患者。手术前,患者佩戴生理监测仪记录生命体征。手术当天,患者完成状态-特质焦虑量表(STAI),并随机分为两组:一组接受基于平板电脑的干预(对照组),另一组在术前等候区接受沉浸式VR体验。干预后,患者重复STAI的状态焦虑部分。
结果显示,平板电脑治疗后总体状态焦虑评分平均下降2.0分,但这一变化未达到统计学意义。然而,20项特定状态焦虑特征中有6项在平板电脑治疗后显著改善,而1项显著恶化。通过VR体验,总体状态焦虑评分平均显著降低2.9分,7项状态焦虑特征得到改善(其中3项与平板电脑干预不重叠)。尽管VR体验使STAI评分下降幅度更大,但两组之间的抗焦虑反应没有显著差异。在生理方面,平板电脑和VR治疗均使心率略有但显著降低,两组之间无差异。
总体而言,研究结果表明,在心脏手术前对老年人进行沉浸式VR体验治疗可显著降低总体焦虑。需要进一步研究确定如何在手术实践中最佳实施此类干预措施,以及此类干预措施是否减少抗焦虑药物的需求并改善患者总体体验。